266 related articles for article (PubMed ID: 12405387)
1. Fibrinolysis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage: rapid reduction in hematoma volume but intensification of delayed edema formation.
Rohde V; Rohde I; Thiex R; Ince A; Jung A; Dückers G; Gröschel K; Röttger C; Küker W; Müller HD; Gilsbach JM
J Neurosurg; 2002 Oct; 97(4):954-62. PubMed ID: 12405387
[TBL] [Abstract][Full Text] [Related]
2. Addition of intravenous N-methyl-D-aspartate receptor antagonists to local fibrinolytic therapy for the optimal treatment of experimental intracerebral hemorrhages.
Thiex R; Weis J; Krings T; Barreiro S; Yakisikli-Alemi F; Gilsbach JM; Rohde V
J Neurosurg; 2007 Feb; 106(2):314-20. PubMed ID: 17410717
[TBL] [Abstract][Full Text] [Related]
3. Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection.
Wagner KR; Xi G; Hua Y; Zuccarello M; de Courten-Myers GM; Broderick JP; Brott TG
J Neurosurg; 1999 Mar; 90(3):491-8. PubMed ID: 10067918
[TBL] [Abstract][Full Text] [Related]
4. The long-term effect of recombinant tissue-plasminogen-activator (rt-PA) on edema formation in a large-animal model of intracerebral hemorrhage.
Thiex R; Küker W; Müller HD; Rohde I; Schröder JM; Gilsbach JM; Rohde V
Neurol Res; 2003 Apr; 25(3):254-62. PubMed ID: 12739233
[TBL] [Abstract][Full Text] [Related]
5. Minor inflammation after surgical evacuation compared with fibrinolytic therapy of experimental intracerebral hemorrhages.
Thiex R; Küker W; Jungbluth P; Kayser C; Müller HD; Rohde I; Gilsbach JM; Rohde V
Neurol Res; 2005 Jul; 27(5):493-8. PubMed ID: 15978174
[TBL] [Abstract][Full Text] [Related]
6. Management of delayed edema formation after fibrinolytic therapy for intracerebral hematomas: preliminary experimental data.
Rohde V; Uzma N; Thiex R; Samadani U
Acta Neurochir Suppl; 2008; 105():101-4. PubMed ID: 19066092
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolysis and aspiration of experimental intracerebral hematoma reduces the volume of ischemic brain in rats.
Deinsberger W; Vogel J; Fuchs C; Auer LM; Kuschinsky W; Böker DK
Neurol Res; 1999 Jul; 21(5):517-23. PubMed ID: 10439435
[TBL] [Abstract][Full Text] [Related]
8. The role of endogenous versus exogenous tPA on edema formation in murine ICH.
Thiex R; Mayfrank L; Rohde V; Gilsbach JM; Tsirka SA
Exp Neurol; 2004 Sep; 189(1):25-32. PubMed ID: 15296833
[TBL] [Abstract][Full Text] [Related]
9. Urokinase versus Alteplase for intraventricular hemorrhage fibrinolysis.
Gaberel T; Montagne A; Lesept F; Gauberti M; Lemarchand E; Orset C; Goulay R; Bertrand T; Emery E; Vivien D
Neuropharmacology; 2014 Oct; 85():158-65. PubMed ID: 24846802
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of brain edema formation.
Xi G; Keep RF; Hoff JT
Neurosurg Clin N Am; 2002 Jul; 13(3):371-83. PubMed ID: 12486926
[TBL] [Abstract][Full Text] [Related]
11. Optimized tPA: A non-neurotoxic fibrinolytic agent for the drainage of intracerebral hemorrhages.
Goulay R; Naveau M; Gaberel T; Vivien D; Parcq J
J Cereb Blood Flow Metab; 2018 Jul; 38(7):1180-1189. PubMed ID: 28741405
[TBL] [Abstract][Full Text] [Related]
12. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
13. Comparison of frame-based and frameless stereotactic hematoma puncture and subsequent fibrinolytic therapy for the treatment of supratentorial deep seated spontaneous intracerebral hemorrhage.
Kim IS; Son BC; Lee SW; Sung JH; Hong JT
Minim Invasive Neurosurg; 2007 Apr; 50(2):86-90. PubMed ID: 17674294
[TBL] [Abstract][Full Text] [Related]
14. Lysis of intracerebral hematoma with stereotactically implanted tissue plasminogen activator polymers in a rabbit model.
Thai QA; Pradilla G; Legnani FG; Kretzer RM; Hsu W; Tamargo RJ
J Neurosurg; 2006 Sep; 105(3):424-9. PubMed ID: 16961138
[TBL] [Abstract][Full Text] [Related]
15. Urokinase, a promising candidate for fibrinolytic therapy for intracerebral hemorrhage.
Tan Q; Chen Q; Niu Y; Feng Z; Li L; Tao Y; Tang J; Yang L; Guo J; Feng H; Zhu G; Chen Z
J Neurosurg; 2017 Feb; 126(2):548-557. PubMed ID: 27104852
[TBL] [Abstract][Full Text] [Related]
16. Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage.
Ducruet AF; Hickman ZL; Zacharia BE; Grobelny BT; Narula R; Guo KH; Claassen J; Lee K; Badjatia N; Mayer SA; Connolly ES
Neurosurgery; 2010 Apr; 66(4):648-55. PubMed ID: 20305489
[TBL] [Abstract][Full Text] [Related]
17. Future perspectives on the fibrinolytic therapy of intracerebral hemorrhages.
Thiex R
Cent Nerv Syst Agents Med Chem; 2011 Jun; 11(2):150-6. PubMed ID: 21521167
[TBL] [Abstract][Full Text] [Related]
18. Hematoma expansion in experimental intracerebral hemorrhage is not altered by peracute treatment with recombinant tissue plasminogen activator.
Pfeilschifter W; Kashefiolasl S; Lauer A; Steinmetz H; Foerch C
Neuroscience; 2013 Oct; 250():181-8. PubMed ID: 23856067
[TBL] [Abstract][Full Text] [Related]
19. No exacerbation of perihematomal edema with intraventricular tissue plasminogen activator in patients with spontaneous intraventricular hemorrhage.
Ziai W; Moullaali T; Nekoovaght-Tak S; Ullman N; Brooks JS; Morgan TC; Hanley DF
Neurocrit Care; 2013 Jun; 18(3):354-61. PubMed ID: 23463422
[TBL] [Abstract][Full Text] [Related]
20. [Leukotriene synthesis after intracerebral hemorrhage: a further indicator for their pathophysiologic significance in the CNS].
Winking M; Deinsberger W; Jödicke A; Böker DK
Zentralbl Neurochir; 1998; 59(2):113-20. PubMed ID: 9674101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
